Newsroom

[Translate to English:] Rasterelektronenmikroskopische Aufnahme einer Escherichia coli-Zelle (rot), die von Bakteriophagen (grün) infiziert wird.

Story

Since the middle of the 20th century, antibiotics have been among the greatest successes in medicine. They save millions of lives every year, prevent complications during operations and make many therapies possible in the first place. But their success has a downside: More and more bacteria are developing strategies to evade the attacks of these drugs. Resistant germs are spreading around the globe, against which hardly any drugs are effective. With the annual World Antimicrobial Resistance Awareness Week (WAAW) from 18 to 24 November, the World Health Organization reminds us how important it is to use antibiotics carefully and how urgently new approaches are needed to continue fighting infections effectively in the future. Almost 20 research groups in the research topic “Novel Anti-Infectives” at the Helmholtz Centre for Infection Research (HZI) are developing new drugs against infectious diseases.

17.11.2025

HZI Campus

HIOH

HIRI

News

The company Clarivate Analytics publishes an annual list of “Highly-cited Researchers” to recognize scientists whose publications have had a particularly large impact on their field. In 2025, three researchers from the Helmholtz Centre for Infection Research (HZI) are once again among the honorees: bioinformatician Prof. Andreas Keller, molecular biologist Dr. Max Kellner and biotechnologist Prof. Marc Stadler were recognized for their widely cited research and the significant contribution they have made to their respective disciplines.

12.11.2025

HZI Campus

HIPS

News

During the 20th anniversary celebrations of the Academy of Sciences in Hamburg , Fabian Leendertz, founding director of the Helmholtz Institute for One Health (HIOH), was inducted as a full member. The ceremony took place on 16 October 2025 in Hamburg. Five new members joined the interdisciplinary network, which currently comprises 145 leading scientists from northern Germany. HIOH is a site of the Helmholtz Centre for Infection Research (HZI).

11.11.2025

HIOH

Dr. Lina Herhaus heads the junior research group “Immune Signalling” at the HZI.

News

Scientist Dr. Lina Herhaus, who heads the junior research group “Immune Signaling” at the Helmholtz Centre for Infection Research (HZI), will receive one of the coveted Exploration Grants from the Boehringer Ingelheim Stiftung starting in March 2026. This program offers outstanding basic researchers in biology, chemistry and medicine the opportunity to explore new directions in research. In addition, Herhaus received the Walther Flemming Award from the German Society of Cell Biology (DGZ) and ibidi GmbH on October 27, 2025. The prize is endowed with 3,000 euros and is awarded to experienced postdoctoral researchers and young scientists for outstanding achievements in cell biology.

29.10.2025

HZI Campus

Interview

Poliomyelitis, also known as polio, is a contagious disease caused by the poliovirus. Thanks to the development of effective vaccines, the poliovirus has been largely eradicated and was endemic in only two countries in 2024. However, until the virus is eradicated worldwide, vaccination protection is important in Germany as well, as the virus could be reintroduced at any time. Epidemiologists at the Helmholtz Centre for Infection Research (HZI) have now shown that many people do not know their vaccination status and cannot find it on their vaccination record. In an interview on the occasion of World Polio Day on October 24, Dr. Carolina Klett-Tammen, deputy head of Clinical Epidemiology in the department “Epidemiology” at the HZI, explains the study results, which have been published in the journal BMC Public Health.

23.10.2025

HZI Campus

Light microscopy of red blood cells, some are infected with Plasmodium

News

It has long been known that bacterial pathogens are becoming increasingly resistant to antibiotics. However, common medications are also becoming less effective against malaria, a tropical disease caused by a parasite. To counteract this development, a research team at the Helmholtz Institute for Pharmaceutical Research Saarland (HIPS), in collaboration with the Swiss Tropical and Public Health Institute (Swiss TPH), has now developed a new drug candidate that can kill the malaria pathogen even when existing drugs are no longer effective. The team has now published its findings in the journal Angewandte Chemie.

22.10.2025

HIPS

Back to the first page
...
14
15
16
17
...
161

HZI in the media

17.09.2026

SR Saarländischer Rundfunk

10.09.2026

TakeToNews

international institutions including Trinity College Dublin, the Helmholtz Institute for One Health, Université Paris 1 Panthéon-Sorbonne,

04.09.2026

News Medical

... der TU Braunschweig und Gruppenleitern am Helmholtz-Zentrum für Infektionsforschung (HZI).

Wie DNA-Viren dem ...

04.09.2026

Regional Heute

... verfügbaren genomischen Ressourcen erheblich. HIPS ist ein Standort des Helmholtz- Zentrums für Infektionsforschung in Zusammenarbeit ...

04.09.2026

Bochumer-Zeitung

Technische Universität Braunschweig, das HZI – Helmholtz-Zentrum für Infektionsforschung in Braunschweig sowie die Medizinische Hochschule ...

03.09.2026

Regierungsportal M-V

... des Exzellenzclusters RESIST und des Helmholtz-Instituts für RNA-basierte Infektionsforschung (HIRI) in Würzburg haben nun ...

03.09.2026

Bio M

... die präzise Zerspanung großer Bauteile. Das Helmholtz-Zentrum für Infektionsforschung in Braunschweig und die Medizinische Hochschule ...

01.09.2026

Regionalupdate.de

... zunehmen. Mit der Gründung des HIOH im Jahr 2021 als Standort des Braunschweiger Helmholtz-Zentrums für ...

31.08.2026

Management & Krankenhaus

Wie man sich mit Mpox anstecken kann und warum sich Personen mit häufig wechselnden Sexpartnern impfen lassen sollten.

28.08.2026

Apotheken Umschau

... des neuen Forschungsgebäudes des Helmholtz-Instituts für One Health (HIOH) in Greifswald (Landkreis Vorpommern-Greifswald) gelegt

. ...

28.08.2026

Tagesschau

How Bacteria Develop Resistance to Antisense Antibiotics—and How Future Therapies Can Be Made Less Susceptible to It

28.08.2026

Bionity.COM

Register now for the HZI newsletter

and stay up to date!

Email address *

We use rapidmail to send our newsletter. I agree that my data entered here will be transmitted to rapidmail. I have taken note of the HZI's privacy policy and have been informed of my rights.